X

We aim to transform protein production to allow universal access to biologics.

AREAS OF FOCUS

Animal Health

20 years’ experience in the development and production of animal vaccines.
200 molecules successfully produced in collaboration with public and private partners, including multiple international pharmaceutical companies.
First dossier for a veterinary vaccine produced using CrisBio® under review by EMA.

Learn more

Human Health

Building on experience in animal health, Algenex is expanding the production of proteins into human health to fully exploit the potential of its technology platforms

Learn more

LATEST NEWS

News

14/06
Company

Call notice for a shareholders’ meeting of ALTERNATIVE GENE ...

Call notice for a shareholders’ meeting of ALTERNATIVE GENE ...
Learn more

News

08/06
Company

Open position: Technician Downstream Area

Creers: be part of Algenex story
Learn more

News

22/02
Company CrisBio Technology

Algenex and Virbac sign international commercial licensing a...

Algenex and Virbac sign commercial licence agreement for the development of a CrisBio®-based vaccine in a major swine indication.
Learn more